Tikun Olam-Cannbit Pharmaceuticals (TKUN.F) Stock Overview

Engages in the production, supply, and marketing of cannabis-based products for medical use in Israel. More details

TKUN.F fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Earnings have declined by 25.1% per year over past 5 years

Does not have a meaningful market cap ($30M)

Negative shareholders equity

Shares are highly illiquid

+ 1 more risk

TKUN.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW479,582 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

479,582 investors already sharing narratives

View all narratives

Tikun Olam-Cannbit Pharmaceuticals Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Tikun Olam-Cannbit Pharmaceuticals
Historical stock prices
Current Share Price	₪0.06
52 Week High	₪0.06
52 Week Low	₪0.06
Beta	0.94
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-95.86%

Recent updates

Shareholder Returns

	TKUN.F	US Pharmaceuticals	US Market
7D	0%	1.6%	-1.4%
1Y	n/a	40.1%	16.4%

Return vs Industry: Insufficient data to determine how TKUN.F performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how TKUN.F performed against the US Market.

Price Volatility

Is TKUN.F's price volatile compared to industry and market?
TKUN.F volatility
TKUN.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.1%
Market Average Movement	7.1%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.2%

Stable Share Price: TKUN.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine TKUN.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1995	19	Ronen Elad	www.tikun-olam.org.il

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services.

Tikun Olam-Cannbit Pharmaceuticals Ltd Fundamentals Summary

How do Tikun Olam-Cannbit Pharmaceuticals's earnings and revenue compare to its market cap?
TKUN.F fundamental statistics
Market cap	US$9.18m
Earnings (TTM)	-US$12.45m
Revenue (TTM)	US$10.85m

0.8x

P/S Ratio

-0.7x

P/E Ratio

Is TKUN.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TKUN.F income statement (TTM)
Revenue	₪34.95m
Cost of Revenue	₪29.53m
Gross Profit	₪5.43m
Other Expenses	₪45.53m
Earnings	-₪40.10m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.47
Gross Margin	15.52%
Net Profit Margin	-114.73%
Debt/Equity Ratio	-227.9%

How did TKUN.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/12/15 20:43
End of Day Share Price	2025/09/17 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tikun Olam-Cannbit Pharmaceuticals Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Tikun Olam-Cannbit Pharmaceuticals LtdOTCPK:TKUN.F Stock Report